Fri, November 11, 2022
Thu, November 10, 2022
Wed, November 9, 2022

Andrew Berens Maintained (BGNE) at Buy with Increased Target to $210 on, Nov 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-210-on-nov-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Berens of SVB Leerink, Maintained "BeiGene, Ltd." (BGNE) at Buy with Increased Target from $200 to $210 on, Nov 10th, 2022.

Andrew has made no other calls on BGNE in the last 4 months.



There are 3 other peers that have a rating on BGNE. Out of the 3 peers that are also analyzing BGNE, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $295 on, Thursday, October 13th, 2022
  • Michael Schmidt of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $205 on, Thursday, October 13th, 2022
  • Xiling Chen of "JP Morgan" Initiated at Buy and Held Target at $296 on, Tuesday, August 9th, 2022

Publication Contributing Sources